Articles

The reduction in plasma free fatty acids (FFA) and insulin resistance that occurs with metformin therapy appears to improve sympathovagal balance in overweight patients with type 2 diabetes.

Blood glucose is often ignored by nurses and physicians who focus only on the reason for admission, not the underlying disease.

Fitness in early adulthood slashes diabetes and metabolic syndrome risk by 50%.

EXERCISE, NOT DIET, MAY BE BEST DEFENSE AGAINST HEART DISEASE Despite widespread attention to diet, calorie intake may not be a major factor in causing death by heart disease, according to a 17-year study of almost 9,800 Americans.

Incidence of Hypoglycemia in Insulin-treated Type 2 Diabetes Higher than Previously Recognized Hypoglycemia may be more common patients with type 2 diabetes who are treated with insulin than was previously thought.

Beta-Blockers Improve Survival Outcomes In Diabetics With Heart Failure Therapy improves outcomes for diabetic patients with chronic heart failure, albeit not to the extent realized by patients without diabetes.

Renal Disease Progresses in Slowly Type 2 Diabetics Type 2 diabetic patients without overt nephropathy have a significant, but slow, course of renal insufficiency.

Combining rosiglitazone, metformin, and insulin aspart improved glucose metabolism in obese type 2 diabetic patients compared with mixed insulin alone.

Excess Risk of Stomach, Uterine Cancer Seen in Type 1 Diabetics The excess risks are most striking for malignancies of the stomach, cervix and endometrium. Diabetics were 4.8 times more likely than the general population to develop cancer

Diabetic women and patients with insulin-dependent diabetes mellitus (IDDM) are at greater risk of cardiac death than other diabetic patients.